期刊文献+

前列腺素E1对行冠状动脉造影或介入治疗老年人肾脏的保护作用 被引量:5

The nephroprotective effects of prostaglandin E1 in the elderly undergoing coronary angiography or intervention treatment
原文传递
导出
摘要 目的探讨前列腺素E1(PGE1)对行冠状动脉造影(CAG)或经皮冠状动脉介入治疗术(PCI)老年人的肾脏保护作用。方法拟行CAG或PCI的患者161例,数字抽签随机分为PGE,组(87例)和对照组(74例)。PGE1组患者术前5d至术后2d用脂微球PGE110μg加入生理盐水100ml中静脉滴注,1次/d。入院和术后48h查血肌酐和胱抑素C(CysC)水平。结果与PGE1组比较,对照组术后血肌酐水平和血清CysC水平升高(均P〈0.01);而肌酐清除率(Ccr)降低(P〈0.05)。对照组对比剂诱导的急性肾损伤(CI-AKI)发生率高于PGE1组,分别为12.2%(9/74)和3.4%(3/87),差异有统计学意义(P〈0.05)。Logistic回归分析结果显示,使用PGE1可降低CI—AKI发生率;而高基线水平的血肌酐、糖尿病增加CIAKI发生率。血清CysC水平与Ccr呈负相关(r=0.615,P%0.01)。结论围术期应用PGE,对行CAG或PCI的老年人具有肾脏保护作用,并能降低CIAKI的发生率。血清CysC水平可作为CI—AK1的辅助诊断指标之一。 Objective To investigate the nephroprotective effects of prostaglandin E1 (PGE1) in the elderly undergoing coronary angiography or intervention. Methods 161 patients undergoing coronary angiography (CAG) or percutaneous coronary intervention (PCI) were randomly assigned to PGE1 group (n=87 cases) and control group (n=74 cases). 10μg lipo-PGE1 added to 100 ml normal saline were administered intravenously once daily for 5 days before and 2 days after the operation. The serum levels of creatinine (Scr) and cystatin C (Cys C) were measured on admission and 48 h after the procedure. Results After the procedure, the levels of Scr and Cys C were increased (P〈0.01) and creatinine clearance (Ccr) was decreased (P〈 0.05) in control group than in PGE1 group. The incidence of contrast-induced acute kidney injury (CI-AKI) in control group [12.2% (9/74)3 was higher than in PGE1 group [3.4%(3/87)] (P〈0.05). The application of PGE1 decreased CLAKI, but high basic level of Scr and diabetes mellitus enhanced the incidence of CI-AKI by logistic regression. The serum levels of Cys C had negative correlation with Ccr (r=-0. 615, P〈0.01). Conclusions Perioperative application of PGE1 has nephroprotective effects in the elderly undergoing CAG or PCI, and decreases the incidence of CI-AKI. The serum levels of Cys C is one of ideal indexes for auxiliary diagnosis of CI-AKI.
出处 《中华老年医学杂志》 CAS CSCD 北大核心 2011年第12期997-999,共3页 Chinese Journal of Geriatrics
基金 广西教育厅科研项目(201106LX103)
关键词 前列腺素E类 血管成形术 经腔 经皮冠状动脉 肾功能不全 急性 Prostaglandins E1 Angiography, transluminal, Percutaneous coronary~ Renal insufficiency, acute
  • 相关文献

参考文献13

  • 1Rihal CS, Textor SC, Grill DE, et al. Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation, 2002, 105: 2259-2264.
  • 2Cepoi V, Onofriescu M, Segall L, et al. The prevalence of chronic kidney disease in the general population in Romania: a study on 60,000 persons. [Epub ahead of print March 01, 2011] Int Urol Nephrol, 2011. http://www. springer. link.
  • 3Moonen M, Fraipont V, Radermacher L, et al. Acute kidney injury: from concept to practice. Nephrol Ther, 2011, 7: 172-177.
  • 4Birck R, Krzossok S, Markowetz F, et al. Acetylcysteine for prevention of contrast nephropathy: meta-analysis. Lancet, 2003, 362 598-603.
  • 5Mehta RL,Kellum JA, Shah SV, et al. Acute kidney injury network: report of an initiative to improve outcomes in acute kidney injury. Crit Care, 2007, 11: R31.
  • 6Lepor NE, Mathur VS. Radiocontrast nephropathy. Curr Inter Cardiol Rep, 2000, 2: 335-341.
  • 7Weisbord SD, Mor MK, Resnick AL, et al. Prevention, incidence, and outcomes of contrast- induced acute kidney injury. Arch Intern Med, 2008, 168: 1325-1332.
  • 8SpargiasK, Adreanides E, Demerouti E, et al. Iloprost prevents contrast-induced nephropathy in patients with renal dysfunction undergoing coronary angiography or intervention. Circulation, 2009, 120: 1793-1799.
  • 9Mahmoud IM, Hussein Ael-A, Sarhan ME, et al. Role of combined L-arginine and prostaglandin E1 in renal ischemia-reperfusion injury. Nephron Physiol, 2007, 105: 57-65.
  • 10Sun D, Liu CX,Ma YY, et al. Protective effect of prostaglandin E1 on renal microvascular injury in rats of acute aristolochic acid nephropathy. Ren Fail, 2011, 33: 225-232.

同被引文献67

  • 1陆佑明,杨威.乌司他丁对老年2型糖尿病病人围术期凝血功能的影响[J].医学临床研究,2012,29(6). 被引量:2
  • 2徐蓉,夏进东,金川连,沈旭峰,毛建强.前列地尔注射液对心功能不全患者冠脉介入术后对比剂肾病的影响[J].医学临床研究,2012,29(6). 被引量:5
  • 3叶云,杨宇,韩卓辉,刘军.前列地尔脂微球载体注射液预防老年人造影剂肾病的临床观察[J].中国新药杂志,2006,15(16):1386-1389. 被引量:8
  • 4Nangaku M. Mechanisms of tubulointerstitial injury in the kidney: final common pathways to end-stage renal failure. Intern Med, 2004,43 : 9-17.
  • 5Glassock RJ, Winearls C. Ageing and the glomerular filtration rate: truths and consequences. Trans Am Clin Climatol Assoc, 2009,120:419-428.
  • 6Canaud B,Morena M,Cristol JP,et al. Beta2-microglobulin,a uremic toxin with a double meaning. Kidney Int,2006,69 : 1297-1299.
  • 7Vallon V. The proximal tubule in the pathophysiology of the diabetic kidney. Am J Physiol Regul Integr Comp Physiol, 2011,300 : 1009-1022.
  • 8Feig DI. Uric acid - a novel mediator and marker of risk in chronic kidney disease. Curr Opin Nephrol Hypertens,2009,18: 526-530.
  • 9James GD, Sealey JE, Alderman M, et al. A longitudinal study of urinary creatinine and creatinine clearance in normal subjects: race,sex,and age differences. Am J Hypertens, 1988,1 : 124-131.
  • 10Glassock RJ,"Winearls C. Ageing and the glomerular filtration rate: truths and consequences. Trans Am Clin Climatol Assoc, 2009 ,120 : 419-428.

引证文献5

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部